Scientifically Speaking

Revisiting the Use of sPLA2-Sensitive Liposomes in Cancer Therapy

Authors:
H. Pourhassan, G. Clergeaud, A. E. Hansen, R. G. Østrem, F. P. Fliedner, F. Melander, O. L. Nielsen, C. K. O’Sullivan, A. Kjær, T. L. Andersen
It is still a pending issue for many “smart” nanocarriers endowed with a controlled and site-specific drug release mechanism to overcome the therapeutic efficacy and minimize therapy-associated side effects obtained by their older brothers, the golden benchmarked nonsensitive formulations.…

join_crs.jpg